4/20
05:21 pm
allo
Form PRE 14A Allogene Therapeutics, For: Apr 20
Medium
Report
Form PRE 14A Allogene Therapeutics, For: Apr 20
4/15
04:36 pm
allo
Form 8-K Allogene Therapeutics, For: Apr 14
High
Report
Form 8-K Allogene Therapeutics, For: Apr 14
4/15
04:33 pm
allo
Form 424B5 Allogene Therapeutics,
High
Report
Form 424B5 Allogene Therapeutics,
4/13
04:45 pm
allo
Form 424B5 Allogene Therapeutics,
High
Report
Form 424B5 Allogene Therapeutics,
4/13
04:09 pm
allo
Form 8-K Allogene Therapeutics, For: Apr 13
High
Report
Form 8-K Allogene Therapeutics, For: Apr 13
4/13
07:45 am
allo
Form 8-K Allogene Therapeutics, For: Apr 13
Low
Report
Form 8-K Allogene Therapeutics, For: Apr 13
4/2
04:48 pm
allo
Form 4 Allogene Therapeutics, For: Mar 31 Filed by: Beneski Benjamin Machinas
Medium
Report
Form 4 Allogene Therapeutics, For: Mar 31 Filed by: Beneski Benjamin Machinas
4/1
07:14 pm
allo
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
Medium
Report
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
3/18
04:07 pm
allo
Form 4 Allogene Therapeutics, For: Mar 16 Filed by: Beneski Benjamin Machinas
Medium
Report
Form 4 Allogene Therapeutics, For: Mar 16 Filed by: Beneski Benjamin Machinas
3/18
04:07 pm
allo
Form 4 Allogene Therapeutics, For: Mar 16 Filed by: Chang David D
Medium
Report
Form 4 Allogene Therapeutics, For: Mar 16 Filed by: Chang David D
3/16
08:20 pm
allo
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
Medium
Report
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
3/16
08:05 pm
allo
Form 144 Allogene Therapeutics, Filed by: Chang David D
Medium
Report
Form 144 Allogene Therapeutics, Filed by: Chang David D
3/12
04:37 pm
allo
Form S-8 Allogene Therapeutics,
Medium
Report
Form S-8 Allogene Therapeutics,
3/12
04:12 pm
allo
Form 10-K Allogene Therapeutics, For: Dec 31
Medium
Report
Form 10-K Allogene Therapeutics, For: Dec 31
3/12
04:07 pm
allo
Form 8-K Allogene Therapeutics, For: Mar 12
Medium
Report
Form 8-K Allogene Therapeutics, For: Mar 12
3/4
05:42 pm
allo
Form 4 Allogene Therapeutics, For: Mar 02 Filed by: Beneski Benjamin Machinas
Medium
Report
Form 4 Allogene Therapeutics, For: Mar 02 Filed by: Beneski Benjamin Machinas
3/2
09:05 pm
allo
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
Medium
Report
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
2/17
05:34 pm
allo
Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie
Medium
Report
Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie
2/13
05:10 pm
allo
Form SCHEDULE 13D/A Allogene Therapeutics, Filed by: PFIZER INC
High
Report
Form SCHEDULE 13D/A Allogene Therapeutics, Filed by: PFIZER INC
2/13
04:22 pm
allo
Form SCHEDULE 13G Allogene Therapeutics, Filed by: Chang David D
High
Report
Form SCHEDULE 13G Allogene Therapeutics, Filed by: Chang David D
2/4
05:20 pm
allo
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Beneski Benjamin Machinas
Medium
Report
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Beneski Benjamin Machinas
2/4
05:18 pm
allo
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Chang David D
Medium
Report
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Chang David D
2/4
05:16 pm
allo
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Parker Geoffrey M.
Medium
Report
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Parker Geoffrey M.
2/4
05:12 pm
allo
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Douglas Earl Martin
Medium
Report
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Douglas Earl Martin
2/4
05:10 pm
allo
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Yoshiyama Annie
Medium
Report
Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Yoshiyama Annie